EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Frailty as a Modifier of Revascularization‐Associated Outcomes in Diabetic Foot Ulcer: A Nationwide Inpatient Study

Krishna O. Sanaka, Nandita Mitra, David J. Margolis

International Wound Journal · 2026-11 · 23 (11)

DOI: 10.1111/iwj.71113 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT We examined whether frailty modifies the association between revascularization and major amputation among hospitalizations for diabetic foot ulcer. We identified adult hospitalizations in the National Inpatient Sample from 2016 through 2022 and classified frailty using the 109‐code Hospital Frailty Risk Score. Survey‐weighted logistic regression assessed major amputation and in‐hospital mortality across four frailty strata, adjusting for demographic and clinical characteristics. Among 2 588 159 diabetic foot ulcer hospitalizations, frailty burden exceeded that of diabetes hospitalizations without foot ulcers. The association between revascularization and major amputation weakened with increasing frailty: adjusted odds ratios were 0.30 (95% confidence interval, 0.26–0.35) for low frailty, 0.68 for intermediate frailty and 0.82 for intermediate‐high frailty. No statistically significant association was observed for high frailty (adjusted odds ratio, 1.05; 95% confidence interval, 0.86–1.29; interaction p < 0.001). Revascularization was associated with lower in‐hospital mortality across frailty strata without significant interaction ( p = 0.413). Frailty modified the observed association with major amputation, whereas mortality associations showed limited heterogeneity. Treatment selection and unmeasured clinical differences preclude causal interpretation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →